Among pediatric patients with pathologically high-risk retinoblastoma, three cycles of chemotherapy were found to have similar results to treatment with the standard six cycles of chemotherapy, ...

Retinoblastoma, a rare eye cancer that affects young children, carries a risk of impaired vision and removal of one or both eyes. It is fatal if left untreated. Previously published in the Journal ...

Retinoblastoma, a rare eye cancer that affects young children, carries a risk of impaired vision and removal of one or both eyes. It is fatal if left untreated. The study, "Advancement in Super ...

The United States Food and Drug Administration (FDA) has previously granted orphan drug designation and rare pediatric disease designation to VCN-01 for the treatment of retinoblastoma. "We are very ...

The United States Food and Drug Administration (FDA) has previously granted orphan drug designation and rare pediatric disease designation to VCN-01 for the treatment of retinoblastoma.